Avascular necrosis (AVN), also called osteonecrosis or bone infarction, is death of bone tissue due to interruption of the blood supply. Early on there may be no symptoms. Gradually joint pain may develop which may limit the ability to move. Complication may include collapse of the bone or nearby joint surface.
Avascular Necrosis Market contains market size and forecasts of Avascular Necrosis in Global, including the following market information:
- Global Avascular Necrosis Market Revenue, 2017-2022, 2023-2028, ($ millions)
- Global top five companies in 2021 (%)
The global Avascular Necrosis market was valued at 490.3 million in 2021 and is projected to reach US$ 613.4 million by 2028, at a CAGR of 3.3% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Trauma Related Avascular Necrosis (AVN) Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Avascular Necrosis include Stryker, Medtronic, Smith and Nephew, Ethicon, Sanofi, Bayer, Pfizer, Merck and Boehringer Ingelheim, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Avascular Necrosis companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Avascular Necrosis Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Avascular Necrosis Market Segment Percentages, by Type, 2021 (%)
- Trauma Related Avascular Necrosis (AVN)
- Non-Trauma Related Avascular Necrosis (AVN)
Global Avascular Necrosis Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Avascular Necrosis Market Segment Percentages, by Application, 2021 (%)
- Hospitals
- Clinics
- Diagnostic Centers
- Ambulatory Surgical Centers
- Others
Global Avascular Necrosis Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Avascular Necrosis Market Segment Percentages, By Region and Country, 2021 (%)
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Nordic Countries
- Benelux
- Rest of Europe
- Asia
- China
- Japan
- South Korea
- Southeast Asia
- India
- Rest of Asia
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- Turkey
- Israel
- Saudi Arabia
- UAE
- Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
- Key companies Avascular Necrosis revenues in global market, 2017-2022 (estimated), ($ millions)
- Key companies Avascular Necrosis revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
- Stryker
- Medtronic
- Smith and Nephew
- Ethicon
- Sanofi
- Bayer
- Pfizer
- Merck
- Boehringer Ingelheim
- Eli Lilly
- Aurobindo Pharma
- Integra LifeSciences
- Zimmer Biomet
- Wright Medical
- Grifols
Industry Market Size
